INSIGHTS ON DRUG DEVELOPMENT
-
![Cell and Gene pharma manufacturing bioprocess GettyImages-1166528646]( "Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins")
Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A ResinsProtein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.
-
![Advancing The Human Liver-Chip Toward FDA Qualification: A New Era For DILI Prediction Bucket]( "Advancing The Human Liver-Chip Toward FDA Qualification")
Advancing The Human Liver-Chip Toward FDA QualificationExplore how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing toward regulatory qualification and scaling into automated studies.
-
![Lonza_AI Drug_OPCU_Feb_2026]( "Lonza Advanced Synthesis Capabilities Update September 2026: AI Drug Manufacturing")
Lonza Advanced Synthesis Capabilities Update September 2026: AI Drug ManufacturingLearn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
![Lipid Formulations In Softgels Enhancing Bioavailability And Therapeutic Efficacy]( "Lipid Formulations In Softgels: Enhancing Bioavailability And Therapeutic Efficacy")
Lipid Formulations In Softgels: Enhancing Bioavailability And Therapeutic EfficacyDiscover how lipid-based softgel formulations can enhance drug absorption, improve bioavailability, and advance drug delivery across a range of therapeutic applications.
-
How To Benchmark Your Digital Transformation Performance And AI-Readiness6/18/2026
AI investment is rising across life sciences, but data challenges stall real-world adoption. Discover what is holding teams back and how to turn AI potential into practical scientific impact.
-
Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk5/18/2026
Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.
-
Streamline Drug Development With A Lab Informatics Platform8/13/2025
Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.
-
High-Throughput IgG Quantification Assay For Cell Line Development4/4/2025
Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.
-
Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs7/29/2025
GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.
DRUG DEVELOPMENT SOLUTIONS
-
![Chip-S1]( "Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery")
From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.
-
![GettyImages-1171312168-lab-development-research]( "A CDMO With Oral Solid Dose And Sterile Injectable Expertise")
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
-
![FLIPR Penta High-Throughput Cellular Screening System]( "FLIPR Penta High-Throughput Cellular Screening System")
An industry-renowned instrument for monitoring GPCRs and ion channels
Powered by a new, optional high-speed EMCCD camera and the new Peak Pro 2 software module, the new FLIPR® Penta High-Throughput Cellular Screening System allows you to measure and analyze peaks of human-derived induced pluripotent stem cells (hiPSCs), differentiated into cardiomyocytes and neurons, up to 100 times per second and quickly cherry pick events such as Early Afterdepolarization-like events (EAD-like events), fibrillation, and irregular beating.
-
![GettyImages-618725044 lab, tablet, teamwork]( "Oligonucleotide Discovery And Development")
Observe how comprehensive R&D support advances therapeutic oligonucleotides from discovery through commercialization with tailored formulation development services across multiple modalities and delivery platforms.
-
![LSC-Cell-Line-Portfolio]( "Optimize Your Cell Line Strategy For Better Viral Vector Production")
Optimize your cell line strategy for better viral vector production.
